Market News & Trends
EMD Millipore Launches Kit for Analyzing NFкB Translocation by Imaging Flow Cytometry
Darmstadt, Germany, November 19, 2014 – EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today introduced the Amnis® NFкB Translocation kit,…
Age-Related Macular Degeneration Treatment Market Value to Exceed $10 Billion by 2023
LONDON, UK (GlobalData), 3 December 2014 - The Age-related Macular Degeneration treatment market across seven major countries (the US, UK, Germany, France, Spain, Italy and…
Global Market for Nucleic Acid Aptamers to Reach $5.4 Billion in 2019
Wellesley, Mass., December 3, 2014 – BCC Research (www.bccresearch.com) reveals in its latest report, Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets, the nucleic…
BioMarin & Prosensa Reach Agreement on Intended Public Offer for 100% of Prosensa's Outstanding Stock
BioMarin Pharmaceutical Inc. and Prosensa Holding N.V. recently announced they have entered into a definitive agreement in which BioMarin will offer to purchase all of…
Trimel Announces Exclusive License Agreement With Endo
Trimel Pharmaceuticals Corporation recently announced the signing of an agreement by its subsidiary, Trimel Biopharma SRL, providing an affiliate of Endo International plc with the…
MRC Technology & Yabao Pharmaceuticals Announce Exclusive Partnership
MRC Technology and Yabao Pharmaceutical Co, Inc. recently announced an exclusive license agreement to discover, develop, and commercialize innovative compounds targeting a specific kinase involved…
Noxilizer Expands Contract Sterilization Operations to Meet Rising Demand
Noxilizer, Inc. recently announced expansion of their contract sterilization operations, triggered by growing customer demand and increased industry acceptance of Noxilizer’s NO2 sterilization - a…
Juno T Cell Therapy Granted FDA Breakthrough Designation
Juno Therapeutics recently announced that the FDA has granted Breakthrough Therapy Designation to the company’s JCAR015 chimeric antigen receptor product candidate. The designation applies for…
Five Prime Therapeutics & Bristol-Myers Squibb Announce Exclusive Clinical Collaboration
Five Prime Therapeutics, Inc. and Bristol-Myers Squibb Company recently announced they have entered into an exclusive clinical collaboration agreement to evaluate the safety, tolerability, and…
Pfanstiehl Launches cGMP-Produced, Parenteral-Grade Mannitol for Pharmaceutical Formulations
Pfanstiehl has announced the launch of a new high purity, low endotoxin, Mannitol (USP/NF, EP, JP), manufactured in the US under strict cGMP, ICH Q7…
Acute Myeloid Leukemia Treatment Market to Witness Modest Growth by 2020
The value of the global Acute Myeloid Leukemia (AML) therapeutics market will increase moderately from $632.6 million in 2013 to $878.6 million by 2020, representing…
Charleston Laboratories & Daiichi Sankyo Initiate Two Phase III Trials
Charleston Laboratories, Inc. and their co-development and co-commercialization partner, Daiichi Sankyo, Inc., initiated two Phase III clinical trials on CL-108, Charleston Laboratories' lead product in…
BioNano Genomics Raises $53 Million to Advance Genomic Mapping Technology
BioNano Genomics, Inc. recently announced the completion of a $53-million Series C financing. Legend Capital and Novartis Venture Fund co-led the round and were joined…
Apellis Pharmaceuticals to acquire Potentia Pharmaceuticals
Apellis Pharmaceuticals recently announced it entered into an agreement to acquire Potentia Pharmaceuticals. As part of the acquisition agreement, Apellis obtained the necessary intellectual property…
Nicox's US Ophthalmic Diagnostics Subsidiary Bought for $20 Million
Nicox S.A. recently announced that Valeant Pharmaceuticals International, Inc. has acquired Nicox’s US diagnostics subsidiary Nicox Inc., in a deal worth up to $20 million.…
Global Market for miRNA Research Tools, Diagnostics & Therapeutics to Reach $1 Billion by 2019
Wellesley, Mass., November 24, 2014 – BCC Research (www.bccresearch.com) reveals in its new report, MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets, the global market…
Knight Sells priority Review Voucher for $125 Million
Knight Therapeutics Inc., through one of its wholly owned subsidiaries, recently announced the sale of its Neglected Tropical Disease Priority Review Voucher (PRV). The PRV…
Horizon Discovery Group & Adarza BioSystems Enter Supply & Licensing Agreement
Cambridge, UK, and St. Louis, MO, 24th November 2014 – Horizon Discovery Group plc (LSE:HZD), a leading provider of research tools to support translational genomics…
Vetter Announces Opening of Office to support Growing Asian Healthcare Market
Vetter recently announced the opening of a new representative office in Singapore. The announcement was made at a ceremony attended by members of local government…
Despite Patent Cliffs, Pharmaceutical Market Shows Signs of Stability
The pharmaceutical market is beginning to show signs of stability, with a review of 30 leading companies highlighting combined revenues of $718.7 billion in 2013,…
